← pool

🏛️ Medicare price negotiation compresses pharma pricing power and biotech returns

The IRA's prescription-drug price cap and Medicare negotiation authority — the second-largest line in the bill — permanently lowers the price the largest buyer in the market pays, cutting pharma revenue, the R&D it funds, and the returns available to biotech investors. Sacks calls it price fixing with a downstream hit to new-drug funding; Friedberg thinks the drug-count effect is small but concedes biotech IRRs fall from ~48% to ~28%.

0 CONVICTION
peaked 58.6 WATCH
DORMANT
band
▼ SHORT XBI
expression · bearish politics-market
PARTIAL
outcome · R +9.8% · α +2.5%
2023-08-20
window closed

⚖ Why this verdict

fully deterministic — evaluate.py replays this from daily closes; nothing below is editable or hand-set

  1. Window: 2022-08-20 → 2023-08-20 — first mention + 12-month horizon, then the window locks.
  2. The call: ▼ SHORT XBI (primary play). XBI fell 9.8% over the window → direction-adjusted R = +9.8% (the call made money).
  3. Benchmark: holding SPY over the same window returned +7.3%α = +9.8 − (+7.3) = +2.5% — what this call made or lost against just owning the index. This is the number the verdict uses.
    Stock-selection read: +17.1% — did XBI move the predicted way relative to the market. The two only differ on a SHORT: this call was right about direction relative to the index but still cost money versus holding it.
  4. Rule fired:
    · HIT — R ≥ +10% AND α ≥ +5
    ▶ PARTIAL — R ≥ +5% OR α ≥ 0
    · MISS — everything else
  5. Credit: supporters of a PARTIAL earn 0.5 each, opposers the inverse — this feeds the scoreboard weights. supported: Chamath, Friedberg, Sacks | proxy-sensitive: IBB→MISS (-0.1%); PFE→HIT (+22.0%)

Conviction timeline

bands: green ≥ 65 · watch ≥ 45 · ember ≥ 15

Plays vs SPY · % since first mention (2022-08-20)

Plays

expressionsymbolkindrelevancerationale
▼ SHORT XBIetf PRIMARY equal-weight biotech — where reduced R&D funding and compressed returns show up first
▼ SHORT IBBetf adjacent large-cap biotech, more exposed to the negotiated-price list itself
▼ SHORT PFEstock adjacent big-pharma proxy for the pricing-power leg of the thesis

Mention log

Friedberg
Friedberg politics-market w=0.84 · n=74 · E92 (2022-08-20) · explicit_prediction · strength 2 ▶ 1:22:34 SUPPORT
“And so I'm hopeful that this will actually provide a more effective market force in allowing the biggest customer in the market to negotiate prices and that the VCs, instead of making 48% IRR, they'll ultimately make 28% IRR on the investments that they're making in biotech startups.”
Sacks
Sacks politics-market w=0.97 · n=88 · E92 (2022-08-20) · explicit_prediction · strength 2 ▶ 1:25:52 SUPPORT
“Well, I mean, you're saying that these drug companies are going to make a lot less money. Well, obviously, that's going to have a downstream impact in the willingness to fund new drugs, new investment, new R&D.”
Chamath
Chamath politics-market w=1.02 · n=96 · E92 (2022-08-20) · sentiment · strength 2 ▶ 1:26:49 SUPPORT
“And, you know, they're in the midst right now of completing a massive facility. I think it's in Virginia where they'll be able to make as much insulin as is needed for the entirety of America for no more than 35 bucks a dose.”

Who built this conviction

each voice's total force on the score — supports and opposes from every mention, weighted exactly as the replay applied them · share = % of all mention-driven movement

Sacks
Sacks w=0.97
1 scoring event · 58% of moves
+33.8 → net +33.8
Friedberg
Friedberg w=0.84
1 scoring event · 21% of moves
+12.5 → net +12.5
Chamath
Chamath w=1.02
1 scoring event · 21% of moves
+12.3 → net +12.3

⏳ decay drained -49.7 over the idea's life — that's time passing, attributed to no one

Score events

episodekindΔafternote
E92 2022-08-20 init +33.8 33.8 E92 born by Sacks (explicit_prediction x2) [w=0.97]
E92 2022-08-20 reinforce +12.5 46.3 E92 Friedberg support x2 (new voice) [w=0.84]
E92 2022-08-20 reinforce +12.3 58.6 E92 Chamath support x2 (new voice) [w=1.02]
E93 2022-08-26 decay -2.3 56.3 E93 silent
E94 2022-09-01 decay -2.3 54.0 E94 silent
E95 2022-09-10 decay -2.2 51.9 E95 silent
E96 2022-09-17 decay -2.1 49.8 E96 silent
E97 2022-09-23 decay -2.0 47.8 E97 silent
E98 2022-10-01 decay -1.9 45.9 E98 silent
E99 2022-10-07 decay -1.8 44.1 E99 silent
E100 2022-10-14 decay -1.8 42.3 E100 silent
E101 2022-10-22 decay -1.7 40.6 E101 silent
E102 2022-10-29 decay -1.6 39.0 E102 silent
E103 2022-11-05 decay -1.6 37.4 E103 silent
E105 2022-11-19 decay -1.5 35.9 E105 silent
E106 2022-12-03 decay -1.4 34.5 E106 silent
E107 2022-12-10 decay -1.4 33.1 E107 silent
E108 2022-12-16 decay -1.3 31.8 E108 silent
E109 2022-12-24 decay -1.3 30.5 E109 silent
E110 2023-01-06 decay -1.2 29.3 E110 silent
E111 2023-01-13 decay -1.2 28.1 E111 silent
E112 2023-01-20 decay -1.1 27.0 E112 silent
E113 2023-01-27 decay -1.1 25.9 E113 silent
E114 2023-02-04 decay -1.0 24.9 E114 silent
E115 2023-02-11 decay -1.0 23.9 E115 silent
E116 2023-02-17 decay -1.0 22.9 E116 silent
E118 2023-03-03 decay -0.9 22.0 E118 silent
E119 2023-03-11 decay -0.9 21.1 E119 silent
E120 2023-03-17 decay -0.8 20.3 E120 silent
E121 2023-03-24 decay -0.8 19.5 E121 silent
E122 2023-03-31 decay -0.8 18.7 E122 silent
E123 2023-04-07 decay -0.7 17.9 E123 silent
E124 2023-04-14 decay -0.7 17.2 E124 silent
E125 2023-04-21 decay -0.7 16.5 E125 silent
E126 2023-04-28 decay -0.7 15.9 E126 silent
E128 2023-05-12 decay -0.6 15.2 E128 silent
E129 2023-05-19 decay -0.6 14.6 E129 silent
E130 2023-05-26 decay -0.6 14.0 E130 silent
E131 2023-06-02 decay -0.6 13.5 E131 silent
E132 2023-06-10 decay -0.5 12.9 E132 silent
E133 2023-06-16 decay -0.5 12.4 E133 silent
E134 2023-06-24 decay -0.5 11.9 E134 silent
E135 2023-07-01 decay -0.5 11.5 E135 silent
E136 2023-07-09 decay -0.5 11.0 E136 silent
E137 2023-07-14 decay -0.4 10.6 E137 silent
E139 2023-07-27 decay -0.4 10.1 E139 silent
E140 2023-08-04 decay -0.4 9.7 E140 silent
E141 2023-08-11 decay -0.4 9.3 E141 silent
E142 2023-08-18 decay -0.4 9.0 E142 silent